Halcyon Bridgeworks
Halcyon Bridgeworks does not cure diseases. It manages the gap between diagnosis and cure.
In 2184, a terminal diagnosis with a viable treatment trajectory โ the patient's biology is compatible with a bespoke compound that Helix Biotech's Personalized Intervention Division can manufacture โ means the patient does not die today. It means the patient is placed in a manufacturing queue. The queue resolves, on average, in fourteen months. Fourteen months is a long time to manage a terminal condition without pharmaceutical intervention. Halcyon Bridgeworks is what you pay to survive that fourteen months without actively dying.
The Hold-On Plan keeps terminal subscribers metabolically suspended โ a managed not-quite-dying โ while their bespoke compound clears the queue. Consciousness cycles down to intermittent orientation windows. The body is maintained. The disease is slowed. The bill runs monthly. And the compound is always, measurably, closer than it was.
When Director Selin Yฤฑlmaz founded the company in 2168, she was two years out from watching her father die in a hospice waiting room โ a man with a viable treatment trajectory and a queue position that arrived three weeks after he did. She built Halcyon so that never happens to anyone else's father. She built it correctly. Halcyon works. The cure arrives. For patients who stay on the bridge, the treatment success rate is 71%.
The remaining 29% did not stay on the bridge. Some of them died in suspension before their compound cleared the queue. Some of them had their queue position expire due to elapsed manufacturing relevance and had to restart the process. And some of them โ 4.3% of those who tried โ successfully filed a Release Petition and chose to leave.
The Hold-On Plan is Halcyon's core product and the mechanism by which terminal care became a subscription service.
Enrollment begins at the Bridge Entry Assessment: a 72-hour period following terminal diagnosis where the patient meets with Halcyon counselors, reviews their treatment trajectory, and confirms enrollment in the Plan. The 72-hour window is designed to prevent impulsive decisions in either direction. In practice, the window is heavily counseled toward enrollment โ the counselors are trained to emphasize queue positions, treatment success rates, and the emotional cost to families of premature release. The word "hospice" does not appear in Bridge Entry Assessment materials.
Once enrolled, the patient enters the Waiting Ward and the bridge state. Orientation windows โ periods of managed consciousness โ occur on a schedule calibrated to the patient's metabolic tolerance, typically every 96 hours. Each orientation window lasts between four and twelve minutes. During an orientation window, the patient can speak to family members, receive care updates from the attending counselor, and, if they wish, express a desire to file for release.
The Release Petition process โ the formal mechanism for choosing to stop โ is available to any enrolled patient. Its existence is disclosed during the Bridge Entry Assessment. Its full requirements are disclosed in section 14 of the enrollment documentation.
The Halcyon Care Board meets quarterly in the Corridor headquarters. It comprises twelve voting members: four Halcyon medical directors, four Halcyon patient advocates (whose performance is measured on sustained enrollment outcome rates), two independent medical ethics representatives (appointed by the Sprawl Medical Council, whose funding is partially derived from a Halcyon charitable gift), and two independent patient representatives (former Hold-On Plan enrollees, selected by the board itself).
The board reviews Release Petitions during its quarterly meetings. A petition is eligible for review only after both required counseling sessions are complete, which typically takes 45โ90 days to schedule. The board's most common finding for denial: "meaningful progress" โ defined as a 15% or greater reduction in compound queue position since the last review. The board finds meaningful progress in approximately 78% of reviewed petitions, because the queue does move, and fifteen percent of a large number is always achievable without being arrival.
After a denial, the patient may appeal. The appeal is reviewed at the next quarterly meeting, 90 days later. If the appeal is also denied, a mandatory 180-day reflection period begins. At the end of the reflection period, the patient may file again. The process, from first petition to successful exit, averages 6โ8 months. During those months, the subscription continues.
The board is not composed of bad people. Every member believes they are preventing premature deaths. They are not wrong. Some patients who would have been approved for release are alive today because they weren't. The 71% treatment success rate includes them. What the board cannot count, because they don't have the data, is how many patients would have preferred not to be saved.
- Cerulean (#4A9BB5) โ water, movement, bridges, calm surfaces that carry things forward - Soft Gray (#E8ECEF) โ clinical neutrality without sterility; the color of rooms that want you to stay - Bridge Ivory (#F5F9FC) โ warmth at the edges; the color of good paper
The Waiting Ward network is operated by Halcyon Bridgeworks across organized Sprawl medical districts and Heights medwings. Each facility is designed by firms that specialize in aspirational medical spaces. The patient pods are called berths โ a nautical metaphor that the brand guide notes "evokes voyage, not confinement." Berth curtains are a soft cerulean. Family lounges have floor-to-ceiling queue displays that show the patient's position in a warm amber sans-serif font, with a gently animated progress indicator. The air is the Relief Corporation proprietary botanical blend. The furniture has no sharp edges. There are plants. The queue display has never shown a position increasing. This is not because positions don't increase โ they occasionally do, when manufacturing recalibration shifts priority โ but because the display software smooths negative movement into a "temporary fluctuation" message while the position restabilizes. The smoothing window is 72 hours. Most recalibrations resolve within 48.
Halcyon counselors wear soft gray with cerulean accents. They are trained not to use the words "waiting," "suspension," "dying," or "giving up." They are trained to use "bridge," "progress," "proximity," and "held." They are not performing โ the training is internalized enough that the language feels natural. The counselors generally believe what they say. This is a feature, not a bug: a counselor who sounds uncertain would undermine the entire architecture of the company.
Born 2130. Lost her father Kemal to a terminal respiratory condition in 2166, two years before she founded Halcyon. The compound that would have saved him was in the queue. It arrived 22 days after he died in a hospice that had no mechanism for waiting productively. She built Halcyon correctly. The science works. The treatment success rate is real. She gives the keynote at every Sprawl Medical Innovation conference, and the keynote is not dishonest โ the numbers she cites are true. What she does not cite, because she genuinely does not think of it as a problem she created, is the Release Petition approval rate. She thinks of it as proof that the system works: 4.3% approval means 95.7% of patients chose to stay on the bridge, and staying on the bridge means the chance of the cure. To her, this is the mission working. She has never personally reviewed a Release Petition. The board handles those.
Halcyon employs approximately 40,000 counselors across all Waiting Ward locations. Counselors are recruited from palliative care backgrounds โ people who chose medicine because they wanted to make dying easier. What they find, in practice, is that Halcyon doesn't do dying. Halcyon does waiting. The adjustment period, per internal HR data, takes most counselors between three and eight months. After that, the retention rate is 94.7%. The counselors who leave almost always leave in months three through eight. The counselors who stay have usually, by month nine, found a way to believe that what they do is helping. Most of them are right. The cure arrives 71% of the time. The remaining 29% is distributed across categories that the internal reporting system describes as "extended bridge period complications." The counselors don't write the reports.
Halcyon hires people who wanted to help dying people. This is not a cynical filter โ it is precisely what the job requires, and the people who apply have generally already proved they can tolerate the proximity to suffering that other industries screen for. What they did not expect, most of them, is that Halcyon does not do dying. Halcyon does waiting. The adjustment period takes most counselors three to eight months. During those months, the counselors who leave, leave. The counselors who stay have usually found, by month nine, a way to believe that what they are doing is what they meant to do.
The internal language is comprehensive. "Bridge period." "Managed care continuity." "Meaningful progress." "Proximity is not distance." These phrases are trained and repeated until they feel natural โ which they eventually do, because they are not wrong in the narrow sense. The compound is coming. The cure is real. Proximity is not distance. The counselors believe this. The belief is required for the work; a counselor who sounds uncertain would undermine the architecture the company is built on. Halcyon has not built a company of liars. It has built a company of people who have organized their beliefs around the correct facts.
The counselor performance metric โ "sustained enrollment outcome rate" โ is not mentioned in training. Counselors know they are measured on "patient advocacy outcomes." The people who designed the metric named it the way they named it because the function it describes is genuine care, and "sustained enrollment" is just what successful care produces. Nobody has needed to explain the connection explicitly, and so nobody has.
Long-form threads that walk through this entity.